CONMED (CNMD) vs iRadimed (IRMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
iRadimed (IRMD) has outperformed CONMED (CNMD) over the past year, gaining 14.9% versus a loss of 3.6%. Over five years, IRMD leads with a +133.1% price change compared with -68.9% for CNMD. CONMED is the larger company by market cap ($1.35 billion vs $1.09 billion), about 1.2 times the size.
On valuation, CONMED trades at a lower forward P/E (9.4x vs 34.6x for iRadimed). iRadimed offers the higher dividend yield (0.91% vs 0.44%).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CNMD | IRMD |
|---|---|---|
| Share price | $45.17 | $84.88 |
| Market cap | $1.35B | $1.09B |
| 1-day change | +2.11% | -0.70% |
| YTD return | +8.94% | -12.14% |
| 1-year return | -3.64% | +14.93% |
| 5-year return | -68.86% | +133.08% |
| P/E ratio (TTM) | 24.41 | 47.42 |
| Forward P/E | 9.45 | 34.60 |
| EPS (TTM) | $1.85 | $1.79 |
| Dividend yield | 0.44% | 0.91% |
| Annual dividend | $0.20 | $0.77 |
| 52-week high | $53.66 | $107.90 |
| 52-week low | $31.44 | $71.34 |
| Distance from 52-week high | -15.83% | -21.34% |
| Analyst consensus | none | none |
| Avg. price target upside | +0.74% | +39.03% |
| Average volume | 493.66K | 126.03K |
| Shares outstanding | 29.95M | 12.79M |
| Employees | 3,900 | 166 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- IRMD has outperformed CNMD by 18.6 percentage points over the past year.
- iRadimed trades at a higher earnings multiple (47.4x vs 24.4x trailing P/E).
About CONMED
CNMD stock →CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 3,900 employees
About iRadimed
IRMD stock →IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device.
Health Care · Medical/Dental Instruments · 166 employees
CNMD vs IRMD FAQ
Which is bigger, CONMED or iRadimed?
CONMED (CNMD) is larger, with a market capitalization of $1.35B compared with $1.09B for iRadimed (IRMD).
Which stock has performed better over the past year, CNMD or IRMD?
IRMD returned +14.93% over the past 12 months, compared with -3.64% for CNMD (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, CNMD or IRMD?
CNMD has the lower trailing P/E at 24.4, versus 47.4 for IRMD. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, CONMED or iRadimed?
iRadimed has the higher yield at 0.91%, compared with 0.44% for CONMED.
Are CONMED and iRadimed in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Electromedical & Electrotherapeutic Apparatus for CONMED and Medical/Dental Instruments for iRadimed.